-
Hyaluronidases are a
family of
enzymes that
catalyse the
degradation of
hyaluronic acid. Karl
Meyer classified these enzymes in 1971, into
three distinct...
- Daratumumab/
hyaluronidase, sold
under the
brand name
Darzalex Faspro, is a fixed-dose
combination medication for the
treatment of
adults with
newly diagnosed...
- Ocrelizumab/
hyaluronidase, sold
under the
brand name
Ocrevus Zunovo, is a fixed-dose
combination medication used for the
treatment of
multiple sclerosis...
- Pertuzumab/trastuzumab/
hyaluronidase, sold
under the
brand name Phesgo, is a fixed-dose
combination medication to
treat adults with HER2-positive breast...
-
Efgartigimod alfa/
hyaluronidase, sold
under the
brand name
Vyvgart Hytrulo, is a
coformulation medication used for the
treatment of
generalized myasthenia...
- Atezolizumab/
hyaluronidase, sold
under the
brand name
Tecentriq Hybreza, is a fixed-dose
combination medication used for the
treatment of non-small cell...
- Trastuzumab/
hyaluronidase, sold
under the
brand name
Herceptin SC
among others, is a fixed-dose
combination medication for the
treatment of HER2-overexpressing...
- macroglobulinemia, a type of non-Hodgkin lymphoma.
Rituximab in
combination with
hyaluronidase human, sold
under the
brand names Mabthera SC and
Rituxan Hycela, is...
-
Hyaluronidase deficiency, also
known as
Mucopolysaccharidosis type IX or MPS IX, is a
condition caused by
mutations in the HYAL1 gene, and is characterized...
-
primarily focused on its
proprietary and
patented recombinant human hyaluronidase enzyme, rHuPH20. The company's
development pipeline is concentrated...
